Quest Labs completes Phase-I expansion, Phase-II Injection Section in progress
QUESTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Phase-I expansion at the existing plant is complete. A new about 12,000 sq ft building housing a finished goods warehouse, blister packing line and quality control section became operational on 16 Sept 2026. Phase-II civil work for the Injection Section is also done; clean room installation is underway, injection machines are expected by end of December 2026, and trial runs are planned for January-February 2027.
Boosts future manufacturing capacity and supports growth. Phase-I is live and can contribute to revenue, while Phase-II should add new capacity in early 2027.